Watch Ticker

IO Biotech, Inc. Common Stock

Go to IO Biotech, Inc. Common Stock Website

$1.97

0.01 (0.51%)

Live

Previous Close

$1.96

Day Range

$0 - $0

Previous Day Range

$1.95 - $2.1994

Market Cap

$141.6 million USD

Day Vol.

Previous Day Vol.

289145

Currency

USD

Primary Exchange

Nasdaq

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

IO Biotech, a clinical-stage biopharmaceutical company, presented new data at the AACR 2025 Annual Meeting, showcasing the dual mechanism and immune activation of its cancer vaccines IO102-IO103 and IO170.

Related tickers: IOBT.

Read Full Article

Io Biotech - IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

IO Biotech presented new preclinical data on its TGF-β-directed peptide vaccine, IO170, which showed reduced tumor growth in cancer models without causing systemic toxicity. The findings support the continued development of this immune-modulatory vaccine as a novel approach for treating a wide range of cancers.

Related tickers: IOBT.

Read Full Article

Trending Tickers

Please sign in to view